Archives
-
EZ Cap™ CPF1/Cas12a mRNA (m1Ψ): Assay Design
2026-09-22
Explore how EZ Cap™ CPF1/Cas12a mRNA (m1Ψ) supports transient Cas12a genome-editing research. This article focuses on assay architecture, evidence boundaries, and how to distinguish delivery, nuclease expression, guide performance, and DNA-repair outcomes.
-
Ampicillin sodium in Recombinant Protein Workflows
2026-09-22
Ampicillin sodium combines dependable plasmid selection with a defined β-lactam mechanism that supports recombinant protein production, antibacterial activity assays, and antibiotic resistance research. This guide connects practical selection parameters with the annexin V purification strategy reported in the reference study, including troubleshooting and assay-design considerations.
-
Tunable Human Intestinal Organoids: Study Insights
2026-09-21
Yang and colleagues developed a human small intestinal organoid system that increases stemness while preserving broad differentiation capacity, overcoming the usual trade-off between expansion and cellular diversity. The study also shows that secretory-to-enterocyte fate, proliferation, and lineage direction can be adjusted through BET, Wnt, Notch, and BMP pathway modulation.
-
ARCA EGFP mRNA: A Better Transfection Readout
2026-09-21
ARCA EGFP mRNA (5-moUTP) enables a more interpretable fluorescence-based transfection control. This guide explains how cap orientation, modified uridines, polyadenylation, and assay architecture distinguish delivery performance from cellular translation effects.
-
Indole-3-pyruvic acid: Applied Workflows
2026-09-20
Indole-3-pyruvic acid connects auxin biosynthesis, fungal metabolite tracing, and AhR-focused immune assays in one experimentally useful workflow. This guide explains how to prepare IPA, select controls, quantify pathway output, and troubleshoot variable responses across plant, fungal, and mammalian models.
-
DAT Neuroimaging and Dopamine Neuron Maturation
2026-09-19
Goggi et al. showed that dopamine transporter PET can longitudinally assess the maturation and presynaptic integration of transplanted human embryonic stem cell-derived dopaminergic neurons in a rat model of Parkinson’s disease. The study also distinguished transporter-based maturation from functional dopamine release, offering a practical framework for evaluating cell therapies before histological endpoint analysis.
-
BipD-Driven Mitophagy in B. pseudomallei Infection
2026-09-18
The reference study identifies a previously unrecognized strategy by which Burkholderia pseudomallei uses its type III secretion protein BipD to redirect a host CUL3 ubiquitin ligase toward mitochondrial quality control. Its central finding is that K63-linked ubiquitination of IMMT at K211 initiates mitophagy, lowers mitochondrial reactive oxygen species, and supports intracellular bacterial survival.
-
2-NBDG Glucose Uptake Assay Kit for HCC
2026-09-18
Map transporter-mediated glucose entry in hepatocellular carcinoma models without radioactivity, then connect uptake phenotypes to sorafenib response and lipid-metabolism biology. This 96-well-compatible workflow also supports viable single-cell analysis, making it useful for heterogeneous cultures, organoids, and metabolic disease models.
-
Bradykinin (BA5201): Vascular Assay Guide
2026-09-17
Bradykinin (SKU BA5201) provides a defined research stimulus for acute studies of endothelial vasodilation, vascular permeability, and related smooth muscle responses. It is suited to tightly controlled in vitro or ex vivo workflows, but its solution should be used promptly and the product should not be used for diagnostic, therapeutic, or medical purposes.
-
Cy3 NHS ester (non-sulfonated): Practical Guide
2026-09-17
Cy3 NHS ester (non-sulfonated) provides a practical route for fluorescently labeling amino groups on soluble proteins, peptides, and amino-modified oligonucleotides or DNA. It should be handled as an organic-solvent reagent rather than added directly to water; for delicate proteins that cannot tolerate DMSO or DMF, a water-soluble sulfo-Cy3 NHS ester is more appropriate.
-
IEM 1460: Designing Better AMPA Blockade Assays
2026-09-16
IEM 1460 is a selective AMPA receptor blocker for dissecting fast excitatory signaling, excitotoxicity, and neuroprotection. This article presents an assay-design framework that separates direct receptor effects from downstream cellular and behavioral outcomes.
-
MK-8745: Applied Aurora A Inhibitor Workflows
2026-09-16
MK-8745 combines strong biochemical potency with a practical workflow for dissecting mitotic arrest, apoptosis, lymphoma biology, and high-risk tumor models. This guide connects the inhibitor to retinoblastoma findings while emphasizing formulation control, orthogonal endpoints, and model-aware interpretation.
-
Bafilomycin A1: V-ATPase Workflow Guide
2026-09-15
Bafilomycin A1 provides a reversible, low-nanomolar way to interrogate proton-dependent organelle biology, from intracellular pH regulation and lysosomal function to osteoclast-mediated bone resorption. This guide connects practical V-ATPase inhibition with a new infection-mitophagy model involving Burkholderia pseudomallei BipD, while emphasizing controls that prevent overinterpretation.
-
Canagliflozin: A Causal Assay Framework
2026-09-15
Canagliflozin is a selective SGLT2 inhibitor whose renal effects extend beyond glucose transport. This article presents a sex-aware assay framework for separating renal glucose reabsorption inhibition from proximal-tubule mitochondrial remodeling in diabetes research.
-
Machine Learning Discovery of Senolytics
2026-09-14
The Nature Communications study presents a cost-conscious machine learning strategy trained solely on published data to identify senolytic compounds despite limited and heterogeneous screening datasets. Experimental validation nominated ginkgetin, periplocin, and oleandrin, demonstrating how computational prioritization can reduce early discovery costs while retaining biological relevance.